Gene · 6625
Papers2,902
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,902
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Overlap Syndrome of Ankylosing Spondylitis and Mixed Connective Tissue Disease in a Male Patient. | Cureus | 2026 | 41994803 | PubTator, text mining | PubMed |
| HSV ICP27 hijacks host splicing factor SRSF3 to regulate pre-mRNA splicing and export for viral gene expression and immune evasion. | PLoS Pathog | 2026 | 41961905 | PubTator, text mining | PubMed |
| HTLV-1-associated uveitis mimicking thyroid-associated ophthalmopathy during antithyroid therapy: a diagnostic pitfall and management challenge. | Endocrinol Diabetes Metab Case Rep | 2026 | 41925323 | PubTator, text mining | PubMed |
| CancerHubs Data Explorer: a web application for investigating mutation-enriched protein interaction hubs in human cancers. | BioData Min | 2026 | 41913220 | PubTator, text mining | PubMed |
| Optical Coherence Tomography Angiography in Patients with Mixed Connective Tissue Disease. | Biomedicines | 2026 | 41898259 | PubTator, text mining | PubMed |
| Reliability of durometry to assess firmness of calcinosis lesions in Juvenile and adult dermatomyositis. | PLoS One | 2026 | 41871052 | PubTator, text mining | PubMed |
| RSRC2 is a novel RNA-binding protein that safeguards mitotic fidelity by interacting with the lncRNA C1QTNF1-AS1. | Nucleic Acids Res | 2026 | 41841495 | PubTator, text mining | PubMed |
| Objective gastrointestinal involvement in patients with systemic sclerosis: Prevalence and clinico-immunological phenotypes in the REMSCLE registry. | Med Clin (Barc) | 2026 | 41812522 | PubTator, text mining | PubMed |
Anti-PM/Scl Antibody-Positive Dermatomyositis With Rapidly Progressive Interstitial Lung Disease in a 19-Year-Old Male: Clinical Implications of a Presumptive Diagnosis Based on Line Immunoassay Positivity. | Cureus | 2026 | 41809306 | PubTator, text mining | PubMed |
| The clinical phenotype of anti-Th/To+ patients in systemic sclerosis: a case-control study within the European Scleroderma Trials and Research cohort. | Ther Adv Musculoskelet Dis | 2026 | 41782907 | PubTator, text mining | PubMed |
| Machine learning-based multiclass model for autoimmune disease diagnosis and classification through nailfold videocapillaroscopy features. | RMD Open | 2026 | 41781159 | PubTator, text mining | PubMed |
| Necrotizing Pneumonia in an Elderly Patient With Chronic Obstructive Pulmonary Disease (COPD): A Case Report. | Cureus | 2026 | 41769515 | PubTator, text mining | PubMed |
| U2AF2 controls alternative splicing in speckle-proximal regions in an RS domain-dependent manner. | Nucleic Acids Res | 2026 | 41761909 | PubTator, text mining | PubMed |
Distinct by Design: Unraveling the Unique Clinical and Transcriptomic Identity of Juvenile Scleromyositis Overlap Compared to Juvenile Systemic Sclerosis and Juvenile Dermatomyositis: Implications for Care and Pathogenesis. | ACR Open Rheumatol | 2026 | 41757646 | PubTator, text mining | PubMed |
| Spatial transcriptomics reveals mechanism of autoimmunity driven by internalized autoantibodies. | medRxiv | 2026 | 41757163 | PubTator, text mining | PubMed |
| Intron Retention Controls Localization of lncRNAs PURPL and MALAT1 to Promote Cell Proliferation and Migration. | bioRxiv | 2026 | 41756867 | PubTator, text mining | PubMed |
| Epigenetic Drivers of Pulmonary Hypertension: Environment Meets Genome. | Cureus | 2026 | 41756345 | PubTator, text mining | PubMed |
| CRISPR/Cas9 screening with destabilized bicistronic fluorescent protein reporter revealed PABPN1 as a hub of regulators for alternative polyadenylation. | Nucleic Acids Res | 2026 | 41755634 | PubTator, text mining | PubMed |
| Novel activating SNRNP70-ALK fusion in congenital infant-type hemispheric glioma displays clinical response to lorlatinib: a case-report. | NPJ Precis Oncol | 2026 | 41748687 | PubTator, text mining | PubMed |
| Targeting fused in sarcoma (FUS): a novel antisense strategy for treating idiopathic pulmonary fibrosis. | Signal Transduct Target Ther | 2026 | 41741410 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6625/papers?page=2